This message was sent to ##Email##
|
|
|
|
|
AST
Annual COP elections are an opportunity to become an active member of the AST. A position on a COP Executive Committee allows AST members to contribute to COP and AST initiatives and to lead colleagues within their specialty area. This year, we have 52 COP EC positions available so there are numerous opportunities to share your leadership skills.
Nominations will be accepted until February 24, 2020, at 11:59 pm ET.
READ MORE
AST
OPTN/UNOS released 11 proposals for public comment on January 22, 2020. The AST's Communities of Practice will be providing feedback to the Policy Committee and Board for Society responses to these requests. Public comment is open to all. Members are encouraged to share their feedback through their COPs and/or as individuals on the OPTN website. If you wish for your individual comments to be considered alongside COP feedback by the Board, please submit them to info@myast.org by February 25. The comment period will close on March 24.
READ MORE
AST
The recent outbreak of a novel coronavirus (2019-nCoV) in Wuhan, Hubei Province, China and the finding of infection in many other countries including the United States has led to questions among transplant programs, Organ Procurement Organizations (OPOs) and patients. Please visit the OPTN website for more information.
The AST's Infectious Disease Community of Practice (IDCOP) developed frequently asked questions sheet to relay information on the current state of 2019-nCoV knowledge after receiving queries from transplant colleagues.
 |
|
Promoted by
Veloxis Pharmaceuticals
Now you can see the different ways that different formulations are released and absorbed in the gastrointestinal system. You’ll also have the opportunity to explore comparative pharmacokinetic results in rapid metabolizers, efficacy data over 2 years, and safety information.
Watch Video
|
|
AST
Join us for an interactive discussion on organ allocation at the 2020 Cutting Edge of Transplantation (CEoT) meeting in Phoenix, AZ. Register and book your housing today.
READ MORE
AST
The Travel for Techniques in Transplantation Research (T3R) Program supports the travel of a scientist to the laboratory of another scientist to acquire a new technique. This program fulfills a goal of the AST Research Network to facilitate bringing novel, cutting edge techniques to transplant biology research labs and clinical scientists.
READ MORE
Advertisement
Veloxis Pharmaceuticals
There are many factors that may put a graft at risk, such as infections, nephrotoxicity, declining adherence, and inadequate immunosuppression. It can be difficult to achieve a balance between overimmunosuppression and underimmunosuppression in kidney transplant patients, putting patients at risk.
Learn more
|
AST
In December 2019, the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2019, also known as the Immuno Bill, was introduced in the House of Representatives. This legislation would extend Medicare coverage of immunosuppressive drugs for kidney transplant recipients, which is currently limited to just 36 months. Contact Congress Today
AST
The Transplantation Society in collaboration with the American Society of Transplantation (AST), acknowledges the contribution of basic science to the field of transplantation by offering Mentee-Mentor awards. The International Transplantation Science Mentee-Mentor Awards aim is to encourage young investigators to submit their research to TTS 2020 and help cover expenses to attend the Congress in Seoul. For more information about the awards and eligibility, click here.
|
|
AST
This year’s CMS Quality Conference has sessions focused on Fostering Innovation in Kidney health, ESRD, and increasing transplantation. CMS will have a specific track of sessions focused on the ETC Kidney Transplant Learning Collaborative where participants will discuss the Learning Collaborative goals to increase kidney transplantation, share best practices to increase kidney utilization and donation, and provide exposure to cutting edge issue discussions, accountability actions and a thoughtful, disciplined approach to improvement.
Kidney Transplant Programs are key to the process. This important work requires your leadership engagement and focus to generate results. CMS and HRSA are asking for our proactive sponsorship and support of these bold aims.
Please attend this meeting and bring your transplant colleagues to generate excitement and commitments as we relentlessly advocate for spreading best practices in order to achieve results.
- Bring at least 1 representative from your transplant program
- Invite at least 1-2 representatives from your OPO to team with you
- Invite representatives from large trauma hospitals to team with you
The CMS Quality Conference, brought to you by the Centers for Medicare & Medicaid Services, will convene 3,000 leaders across the health care spectrum, to explore how patients, advocates, providers, researchers, and champions in health care quality improvement can develop and spread solutions to address America’s most pervasive health system challenges. Participants will experience interactive learning sessions, master classes for continuing education credit, and engaging seminars and keynote addresses spanning vast areas.
READ MORE
|
TruGraf® - The 1st and only non-invasive test to rule out “silent" subclinical rejection in stable kidney transplant recipients
The only test to be reimbursed as an alternative to surveillance biopsies
Developed by Clinicians for Clinicians
Learn More
|
|
|
|
|
Reach Your Prospects Every Week
Thousands of industry professionals subscribe to association news briefs, which allows your company to push messaging directly to their inboxes and take advantage of the association's brand affinity.
Connect with Highly Defined Buyers and Maximize Your Brand Exposure
|
|
|
|
|
AST
The Transplant Nephrology Core Curriculum (TNCC) is an online program jointly provided by the American Society of Nephrology and the American Society of Transplantation. The TNCC focuses on key information needed to prepare for the American Board of Internal Medicine Nephrology Board Certification and Maintenance of Certification examinations.
READ MORE
AST
Transplant professionals have increasing demands on their time. Finding time in one’s day to attend conferences or to read journals is challenging. Transplant in 10 is intended to provide transplant professionals with short, easily accessible videos on key and updated topics in 10 minutes.
READ MORE
|
|
| | UPCOMING EDUCATION EVENTS |
AST
March 12, 2020 | 2 pm ET | Online Activity
For more information, click here
AST
March 24, 2020 | 2 pm ET | Online Activity
For more information, click here
Journal of Hepatology via Science Direct
Patients with acute-on-chronic liver failure (ACLF) can be listed for liver transplantation (LT) because LT is the only curative treatment option. We evaluated whether the clinical course of ACLF, particularly ACLF-3, between the time of listing and LT affects 1-year post-transplant survival.
READ MORE
JAMA Network
Living kidney donation is associated with increased long-term risk of end-stage renal disease (ESRD). An early postdonation marker of ESRD risk could improve postdonation risk assessment and counseling for kidney donors and allow early intervention for donors at increased risk. The objective of the study was to determine the association between renal function in the first six months postdonation and subsequent risk of ESRD in kidney donors.
READ MORE
JAMA Network
In this cohort study of 166 patients with stage 5 chronic kidney disease and 87 patients with hypertension only to assess change to cardiovascular functional reserve after improving the uremic milieu through a kidney transplant using state-of-the-art cardiopulmonary exercise testing, improved cardiovascular functional reserve was seen one year after kidney transplant in the absence of significant alterations in left ventricular morphologic findings.
READ MORE
American Association of the Study of Liver Diseases
Recipients of simultaneous liver‐kidney transplants (SLKT) have a lower risk of rejection compared with recipients of kidney transplants alone. However, there is disagreement about the impact of pre‐transplant anti‐HLA sensitization on patient and kidney graft survival in the long‐term. The aim of the study was to evaluate the impact of the recipient immunological risk and comorbidities in renal graft outcome on SLKT.
READ MORE
American Journal of Transplantation via Wiley Online Library
Variability in transplant access exists, but barriers to referral and evaluation are underexplored due to lack of national surveillance data. Researchers examined referral for kidney transplantation evaluation and start of the evaluation among 34 857 incident, adult (18‐79 years) end‐stage kidney disease patients from 690 dialysis facilities in the United States Renal Data System from Jan. 1, 2012, through Aug. 31, 2016, followed through February 2018.
READ MORE
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
